Posted on 1/22/2024
Celnovte has consistently received excellent results in the international authoritative pathology quality assessment organizations—NordiQC Immunohistochemistry.
Last year, all antibodies submitted by Celnvote for evaluation achieved exceptional results including #HER2, #ER, #PD-L1 (TPS/CPS), #CK8/18, #PSA, #CD138, #CD5, #CD10, #MSH2, #TTF1, #p40, and #p53.
Celnovte is commited to providing integrated pathology diagnostic solutions and better patient care!